| Synonyms: | |
| Status: | Approved (1959) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N05AB02 |
| UNII: | S79426A41Z |
| InChI Key | PLDUPXSUYLZYBN-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H26F3N3OS |
| Molecular Weight | 437.53 |
| AlogP | 4.31 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 29.95 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 30.0 |
| Primary Target | |
|---|---|
| D2 receptor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 69-23-8 |
| ChEBI | 5123 |
| ChEMBL | CHEMBL726 |
| DrugBank | DB00623 |
| DrugCentral | 1212 |
| EPA CompTox | DTXSID2023068 |
| FDA SRS | S79426A41Z |
| Human Metabolome Database | HMDB0014761 |
| Guide to Pharmacology | 204 |
| KEGG | C07010 |
| PharmGKB | PA449676 |
| PubChem | 3372 |
| SureChEMBL | SCHEMBL19221 |
| ZINC | ZINC000019203912 |